Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-23

Clinical Trial Update: Dexamethasone Palmitate for PONV After Craniotomy [NA]

View source ↗

Summary

A clinical trial is evaluating dexamethasone palmitate for preventing postoperative nausea and vomiting after craniotomy, and the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexamethasone Palmitate (dexamethasone palmitate)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Postoperative Nausea and Vomiting | NA | Status: RECRUITING